<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1488</article-id><article-id pub-id-type="doi">10.36691/RJA1488</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Case reports</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Клинические случаи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Clinical characteristics of chronic spontaneous urticaria in patients with Common variable immune deficiency and hypogammaglobulinemia</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности течения хронической спонтанной крапивницы у пациентов с общей вариабельной иммунной недостаточностью и гипогаммаглобулинемией</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1508-0640</contrib-id><contrib-id contrib-id-type="spin">8929-7644</contrib-id><name-alternatives><name xml:lang="en"><surname>Latysheva</surname><given-names>Tatiana V.</given-names></name><name xml:lang="ru"><surname>Латышева</surname><given-names>Татьяна Васильевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор</p></bio><email>tvlat@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1606-205X</contrib-id><contrib-id contrib-id-type="spin">2063-7973</contrib-id><name-alternatives><name xml:lang="en"><surname>Latysheva</surname><given-names>Elena A.</given-names></name><name xml:lang="ru"><surname>Латышева</surname><given-names>Елена Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д.м.н.</p></bio><email>ealat@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8279-2173</contrib-id><contrib-id contrib-id-type="spin">4547-3948</contrib-id><name-alternatives><name xml:lang="en"><surname>Danilycheva</surname><given-names>Inna V.</given-names></name><name xml:lang="ru"><surname>Данилычева</surname><given-names>Инна Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>ivdanilycheva@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0800-5960</contrib-id><contrib-id contrib-id-type="spin">5963-4062</contrib-id><name-alternatives><name xml:lang="en"><surname>Frolov</surname><given-names>Evgeny A.</given-names></name><name xml:lang="ru"><surname>Фролов</surname><given-names>Евгений Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><email>frolovevgeny@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia</institution></aff><aff><institution xml:lang="ru">Государственный научный центр «Институт иммунологии» Федерального медико-биологического агентства</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2021-12-22" publication-format="electronic"><day>22</day><month>12</month><year>2021</year></pub-date><pub-date date-type="pub" iso-8601-date="2021-12-14" publication-format="electronic"><day>14</day><month>12</month><year>2021</year></pub-date><volume>18</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>140</fpage><lpage>148</lpage><history><date date-type="received" iso-8601-date="2021-09-28"><day>28</day><month>09</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-12-19"><day>19</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Фармарус Принт Медиа</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2024-01-14"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/1488">https://rusalljournal.ru/raj/article/view/1488</self-uri><abstract xml:lang="en"><p>Chronic spontaneous urticaria is a prevalent disease that is associated with various autoimmune, infectious (viral, bacterial, parasitic), and non-infectious inflammatory pathologies, and could occur in the symptom complex of other diseases, such as primary immunodeficiencies. Nowadays, data on the features of chronic spontaneous urticaria in patients with primary immunodeficiencies are accumulating. Common variable immune deficiency takes a special place in clinical practice among primary immunodeficiencies with impaired antibody synthesis and is associated with late-onset in adulthood, as well as the heterogeneity of its clinical manifestations, such as infectious and non-infectious complications, which can serve as a background for chronic urticaria development. Intravenous Immunoglobulin (IVIg) replacement therapy is the mainstay of treatment and prevention of infectious complications in these patients; however, immunomodulatory and anti-inflammatory effects can occur in high doses.</p> <p>Herein, presented two clinical cases of patients with common variable immune deficiency and one with hypogammaglobulinemia who suffer from chronic spontaneous urticaria. The peculiarities of IVIg replacement therapy at urticaria were noted in these patients. The discussion presents the review of world literature and proposes key features for further investigations.</p></abstract><trans-abstract xml:lang="ru"><p>Хроническая спонтанная крапивница ― распространённое заболевание, которое может ассоциироваться с различными аутоиммунными, инфекционными (вирусными, бактериальными, паразитарными) и неинфекционными воспалительными заболеваниями, а также встречаться в симптомокомплексе других заболеваний, таких как первичные иммунодефициты. В настоящее время накапливаются данные об особенностях течения хронической спонтанной крапивницы у пациентов с первичными иммунодефицитами. Среди первичных иммунодефицитов с нарушением синтеза антител в клинической практике особое место занимает общая вариабельная иммунная недостаточность. Для этого заболевания характерны дебют во взрослом возрасте, а также гетерогенность клинических проявлений, в том числе инфекционных и неинфекционных осложнений, которые в совокупности могут послужить фоном для развития хронической спонтанной крапивницы. Заместительная терапия иммуноглобулинами для внутривенного введения является основным методом лечения у таких пациентов, направленным на купирование и профилактику инфекционных осложнений, однако в высоких дозах она может оказывать иммуномодулирующий и противовоспалительный эффекты.</p> <p>В статье представлены два клинических случая пациентов с общей вариабельной иммунной недостаточностью и один клинический случай пациентки с гипогаммаглобулинемией, страдающих хронической рецидивирующей крапивницей. Отмечены особенности влияния заместительной терапии внутривенными иммуноглобулинами на течение крапивницы у данных пациентов. В разделе обсуждение представлены данные мировой литературы и предложены ключевые положения для дальнейшего изучения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>chronic urticaria</kwd><kwd>hypogammaglobulinemia</kwd><kwd>immunoglobulins for intravenous administration</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хроническая крапивница</kwd><kwd>гипогаммаглобулинемия</kwd><kwd>иммуноглобулины для внутривенного введения</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy. 2020;75(2):423–432. doi: 10.1111/all.14037</mixed-citation><mixed-citation xml:lang="ru">Fricke J., Ávila G., Keller T., et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis // Allergy. 2020. Vol. 75, N 2. P. 423–432. doi: 10.1111/all.14037</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Danilycheva IV, Ilyina NI, Luss LV, et al. Federal clinical guidelines for the diagnosis and treatment of urticaria. Russian Allergol J. 2016;(1):38–46. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Данилычева И.В., Ильина Н.И., Лусс Л.В., и др. Федеральные клинические рекомендации по диагностике и лечению крапивницы // Российский аллергологический журнал. 2016. № 1. С. 38–46.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA²LEN/EDF/WAO guideline for the deﬁ nition, classiﬁ ca-tion, diagnosis and management of urticaria. Allergy. 2018;73(7):1393–1414. doi: 10.1111/all.13397</mixed-citation><mixed-citation xml:lang="ru">Zuberbier T., Aberer W., Asero R., et al. The EAACI/GA²LEN/EDF/WAO guideline for the deﬁ nition, classiﬁ cation, diagnosis and management of urticaria // Allergy. 2018. Vol. 73, N 7. P. 1393–1414. doi: 10.1111/all.13397</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Mikryukova NV, Kalinina NM. Immunopathogenesis of chronic urticaria in adults (scientific review). Preventive Clin Med. 2020;(3):77–85. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Микрюкова Н.В., Калинина Н.М. Иммунопатогенез хронической крапивницы у взрослых (научный обзор) // Профилактическая и клиническая медицина. 2020. № 3. С. 77–85.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Danilycheva IV. Autoimmune urticaria. Doctor. Ru. 2010;(2):41–44. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Данилычева И.В. Аутоиммунная крапивница // Доктор. Ру. 2010. № 2. С. 41–44.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64(9):1256–1268. doi: 10.1111/j.1398-9995.2009.02132.x</mixed-citation><mixed-citation xml:lang="ru">Konstantinou G.N., Asero R., Maurer M., et al. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria // Allergy. 2009. Vol. 64, N 9. P. 1256–1268. doi: 10.1111/j.1398-9995.2009.02132.x</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Altrichter S, Peter HJ, Pisarevskaja D, et al. IgE mediated autoallergy against thyroid peroxidase ― a novel pathomechanism of chronic spontaneous urticaria? PloS One. 2011;6;(4):e14794. doi: 10.1371/journal.pone.0014794</mixed-citation><mixed-citation xml:lang="ru">Altrichter S., Peter H.J., Pisarevskaja D., et al. IgE mediated autoallergy against thyroid peroxidase ― a novel pathomechanism of chronic spontaneous urticaria? // PloS One. 2011. Vol. 6, N 4. Р. e14794. doi: 10.1371/journal.pone.0014794</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Bracken SJ, Abraham S, MacLeod AS. Autoimmune theories of chronic spontaneous urticaria. Front Immunol. 2019;10:627. doi: 10.3389/fimmu.2019.00627</mixed-citation><mixed-citation xml:lang="ru">Bracken S.J., Abraham S., MacLeod A.S. Autoimmune theories of chronic spontaneous urticaria // Front Immunol. 2019. N 10. Р. 627. doi: 10.3389/fimmu.2019.00627</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Abolhassani H, Amirkashani D, Parvaneh N, et al. Autoimmune phenotype in patients with common variable immunodefici.ency J Investig Allergol Clin Immunol. 2013;23(5):323–329.</mixed-citation><mixed-citation xml:lang="ru">Abolhassani H., Amirkashani D., Parvaneh N., et al. Autoimmune phenotype in patients with common variable immunodeficiency // J Investig Allergol Clin Immunol. 2013. Vol. 23, N 5. Р. 323–329.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol. 2008;28(1):42–45. doi: 10.1007/s10875-008-9182-7</mixed-citation><mixed-citation xml:lang="ru">Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency // J Clin Immunol. 2008. Vol. 28, Suppl 1. Р. 42–45. doi: 10.1007/s10875-008-9182-7</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Azizi G, Tavakol M, Rafiemanesh H, et al. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2017;13(11):1099–1106. doi: 10.1080/1744666X.2017.1384312</mixed-citation><mixed-citation xml:lang="ru">Azizi G., Tavakol M., Rafiemanesh H., et al. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies // Expert Rev Clin Immunol. 2017. Vol. 13, N 11. Р. 1099–1106. doi: 10.1080/1744666X.2017.1384312</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Xiao X, Miao Q, Chang C, et al. Common variable immunodeficiency and autoimmunity ― an inconvenient truth. Autoimmun Rev. 2014;13;(8):858–864. doi: 10.1016/j.autrev.2014.04.006</mixed-citation><mixed-citation xml:lang="ru">Xiao X., Miao Q., Chang C., et al. Common variable immunodeficiency and autoimmunity ― an inconvenient truth // Autoimmun Rev. 2014. Vol. 13, N 8. Р. 858–864. doi: 10.1016/j.autrev.2014.04.006</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Tangye, SG, Al-Herz, W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40:66–81. doi: 10.1007/s10875-019-00737-x</mixed-citation><mixed-citation xml:lang="ru">Tangye S.G., Al-Herz W., Bousfiha A., et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification // J Clin Immunol. 2020. Vol. 40. Р. 66–81. doi: 10.1007/s10875-019-00737-x</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Kondratenko IV, Bologov AA. Primary immunodeficiency: textbook. Moscow: Media Index; 2020. 791 р. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Кондратенко И.В., Бологов А.А. Первичные иммунодефициты: учебное пособие. Москва: ИндексМед Медиа, 2020. 791 с.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Hide M, Francis DM, Grattan C, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328(22):1599–1604. doi: 10.1056/NEJM199306033282204</mixed-citation><mixed-citation xml:lang="ru">Hide M., Francis D.M., Grattan C., et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria // N Engl J Med. 1993. Vol. 328, N 22. Р. 1599–1604. doi: 10.1056/NEJM199306033282204</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105(4):664–672. doi: 10.1067/mai.2000.105706</mixed-citation><mixed-citation xml:lang="ru">Greaves M. Chronic urticaria // J Allergy Clin Immunol. 2000. Vol. 105, N 4. Р. 664–672. doi: 10.1067/mai.2000.105706</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Kolkhir P, Borzova E, Grattan C, et al. Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review. Autoimmun Rev. 2017;16;(12):1196–1208. doi: 10.1016/j.autrev.2017.10.003</mixed-citation><mixed-citation xml:lang="ru">Kolkhir P., Borzova E., Grattan C., et al. Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review //Autoimmun Rev. 2017. Vol. 16. N 12. Р. 1196–1208. doi: 10.1016/j.autrev.2017.10.003</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Latysheva EA. Primary immunodeficiency in adults: features of diagnosis and treatment [dissertation abstract]. Moscow; 2019. 48 р. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Латышева Е.А. Первичные иммунодефициты у взрослых: особенности диагностики и лечения: Автореф. дис. ... докт. мед. наук. Москва, 2019. 48 с.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Santos CV, Yacoub M. Chronic urticaria and common variable immunodeficiency (CVID): an association to remember BMJ Case Rep. 2021;14;(2):e239733. doi: 10.1136/bcr-2020-239733</mixed-citation><mixed-citation xml:lang="ru">Santos C.V., Yacoub M. Chronic urticaria and common variable immunodeficiency (CVID): an association to remember // BMJ Case Rep. 2021. Vol. 14, N 2. P. e239733. doi: 10.1136/bcr-2020-239733</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Comberiati P, Costagliola G, Carli N, et al. G Refractory chronic spontaneous urticaria treated with omalizumab in an adolescent with common variable immunodeficiency. Front Immunol. 2019;10:1700. doi: 10.3389/fimmu.2019.01700</mixed-citation><mixed-citation xml:lang="ru">Comberiati P., Costagliola G., Carli, N., et al. Refractory chronic spontaneous urticaria treated with omalizumab in an adolescent with common variable immunodeficiency // Front immunol. 2019. Vol. 10. Р. 1700. doi: 10.3389/fimmu.2019.01700</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001;291;(5503):484–486. doi: 10.1126/science.291.5503.484</mixed-citation><mixed-citation xml:lang="ru">Samuelsson A., Towers T.L., Ravetch J.V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor // Science. 2001. Vol. 291, N 5503. Р. 484–486. doi: 10.1126/science.291.5503.484</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Nimmerjahn F, Ravetch JV. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med. 2007;204;(1):11–15. doi: 10.1084/jem.20061788</mixed-citation><mixed-citation xml:lang="ru">Nimmerjahn F., Ravetch J.V. The antiinflammatory activity of IgG: the intravenous IgG paradox // J Exp Med. 2007. Vol. 204, N 1. Р. 11–15. doi: 10.1084/jem.20061788</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Altschul A, Cunningham-Rundles C. Chronic urticaria and angioedema as the first presentations of common variable immunodeficiency J Allergy Clin Immunol. 2002;110;(4):664–665 doi: 10.1067/mai.2002.127002</mixed-citation><mixed-citation xml:lang="ru">Altschul A., Cunningham-Rundles C. Chronic urticaria and angioedema as the first presentations of common variable immunodeficiency // J Allergy Clin Immunol. 2002. Vol. 110, N 4. Р. 664–665 doi: 10.1067/mai.2002.127002</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Smith AA, Humphrey J, McAuley JB, et al. Common variable immunodeficiency presenting as chronic urticaria. J Am Acad Dermatol. 2008;59(2 Suppl 1):S40–S41. doi: 10.1016/j.jaad.2007.09.011</mixed-citation><mixed-citation xml:lang="ru">Smith A.A., Humphrey J., McAuley J.B., et al. Common variable immunodeficiency presenting as chronic urticaria // J Am Acad Dermatol. 2008. Vol. 59, N 2, Suppl 1. Р. S40–S41. doi: 10.1016/j.jaad.2007.09.011</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Frossi B, De Carli R, De Carli M. Chronic spontaneous urticaria in patients with common variable immunodeficiency. EMJ. 2018;3(4):95–102.</mixed-citation><mixed-citation xml:lang="ru">Frossi B., De Carli R., De Carli M. Chronic spontaneous urticaria in patients with common variable immunodeficiency // EMJ. 2018. Vol. 3, N 4. Р. 95–102.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Chechetkin AV, Bessmeltsev SS, Romanenko NA. The use of intravenous human immunoglobulin (immunovenin) in clinical practice. Methodological recommendations. Saint Petersburg; 2017. 7 р. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Чечеткин А.В., Бессмельцев С.С., Романенко Н.А. Применение внутривенного иммуноглобулина человека (иммуновенина) в клинической практике. Методические рекомендации. Санкт-Петербург, 2017. 7 с.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001;291(5503):484–486. doi: 10.1126/science.291.5503.484</mixed-citation><mixed-citation xml:lang="ru">Samuelsson A., Towers T.L., Ravetch J.V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor // Science. 2001. Vol. 291, N 5503. Р. 484–486. doi: 10.1126/science.291.5503.484</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Asero R. Are IVIG for chronic unremitting urticaria effective? Allergy. 2000;55(11):1099–1101. doi: 10.1034/j.1398-9995.2000.00829.x</mixed-citation><mixed-citation xml:lang="ru">Asero R. Are IVIG for chronic unremitting urticaria effective? // Allergy. 2000. Vol. 55, N 11. Р. 1099–1101. doi: 10.1034/j.1398-9995.2000.00829.x</mixed-citation></citation-alternatives></ref></ref-list></back></article>
